Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.83

€0.83

10.000%
0.073
10.000%
€9.23
 
16.05.24 / Tradegate WKN: A3DMHB / Symbol: ENVB / Name: Enveric Biosciences / Stock / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Enveric Biosciences Inc. Stock

A very strong showing by Enveric Biosciences Inc. today, with an increase of €0.073 (10.000%) compared to yesterday's price.
Based on 1 Buy predictions and 2 Sell predictions the sentiment towards Enveric Biosciences Inc. is rather balanced.
On the other hand, the target price of 9 € is above the current price of 0.83 € for Enveric Biosciences Inc., so the potential is actually 980.43%.
Our community identified positive and negative aspects for Enveric Biosciences Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Enveric Biosciences Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.

Pros and Cons of Enveric Biosciences Inc. in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) 0.97%
Target price 9.227
Change
Ends at 30.01.25

Enveric Biosciences, Inc. (NASDAQ: ENVB) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.
Ratings data for ENVB provided by MarketBeat
Show more